DBS cuts Sea target as Shopee spending weighs on profit growth

FBN Securities initiates Datadog stock coverage with outperform rating

Investing.com · News 9m ago

H.C. Wainwright reiterates Candel Therapeutics stock rating on trial data

Investing.com · News 9m ago

H.C. Wainwright reiterates Agomab stock rating on trial data

Investing.com · News 9m ago

H.C. Wainwright reiterates Cullinan Oncology stock rating on NDA filing

Investing.com · News 9m ago

H.C. Wainwright reiterates Buy on Wave Life Sciences stock

Investing.com · News 9m ago

H.C. Wainwright reiterates Buy on Artiva stock, $35 target

Investing.com · News 9m ago

OPEC+ quotas review delayed amid Iran war - report

Investing.com · Investing_news 13m ago

OPEC+ quotas review delayed amid Iran war - report

Investing.com · News 13m ago

Wedbush cuts Foghorn Therapeutics stock rating on drug setback

Investing.com · News 15m ago

Analysis-Nike’s struggles test investor confidence in CEO Hill’s turnaround effort

Investing.com · News 15m ago